KDK KDK Issuance of non-redemption common stock in connection with reverse recapitalization

Issuance of non-redemption common stock in connection with reverse recapitalization at other companies

Prospect CapitalPSEC

$16.85M-38.9%

Kestra Medical Technologies, Ltd. Common StockKMTS

$103.4M+451%

Opendoor Technologies IncOPEN

$296M—

HTF

Heartflow, Inc. Common StockHTFL

$42.24M—

StepStone Group Inc.STEP

$0—

Evolution Metals & Technologies Corp. EMAT

$1.47M-52.0%

Other financials

Income statement

See full

Revenue$1.8M+24.4%

Operating income-$37.9M-104%

Net income$26.5M+121%

EPS (diluted)$0.10+105%

Balance sheet

See full

Cash & equivalents$66.4M+247%

Total debt$58.4M+1,068%

Total equity-$245.9M+34.7%

Total assets$130.8M-76.5%

Cash flow

See full

Operating cash flow-$29.5M-78.7%

CapEx$5.5M+138%

Free cash flow-$35.0M-86.0%

Valuation

See full

Market cap$1.05B-18.6%

Enterprise value$1.04B—

P/S252.8×—

Profitability

See full

Operating margin-2,695.8%—

Net margin-10,366.9%—

FCF margin-278%—

Returns & leverage

See full

Return on equity-21.5%—

Debt / equity-0.2×—

Current ratio3.7×+3.4×

Where this comes from

Reported directly by KDK in its filing.

Tagged under the XBRL concept kdk:IssuanceOfNonRedemptionCommonStockInConnectionWithReverseRecapitalization.

The official record: KDK’s 10-K, filed March 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about KDK's issuance of non-redemption common stock in connection with reverse recapitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is KDK's issuance of non-redemption common stock in connection with reverse recapitalization?: KDK (KDK) reported issuance of non-redemption common stock in connection with reverse recapitalization of $805K in Q4 2025.
What does issuance of non-redemption common stock in connection with reverse recapitalization mean?: Represents the issuance of common stock that is not subject to redemption rights, typically issued as part of a reverse recapitalization or business combination. This metric highlights the creation of permanent equity capital that is not tied to redemption obligations. It serves as a measure of the company's stable equity base following a significant corporate restructuring.